These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34771163)

  • 1. Synthesis and Antiproliferative Activity of 2,4,6,7-Tetrasubstituted-2
    Razmienė B; Řezníčková E; Dambrauskienė V; Ostruszka R; Kubala M; Žukauskaitė A; Kryštof V; Šačkus A; Arbačiauskienė E
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of N-aryl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridin-7-amines and their photodynamic properties in the human skin melanoma cell line G361.
    Razmienė B; Vojáčková V; Řezníčková E; Malina L; Dambrauskienė V; Kubala M; Bajgar R; Kolářová H; Žukauskaitė A; Arbačiauskienė E; Šačkus A; Kryštof V
    Bioorg Chem; 2022 Feb; 119():105570. PubMed ID: 34953323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-mitotic activity of 2,4- or 2,6-disubstituted- and 2,4,6-trisubstituted-2H-pyrazolo[4,3-c]pyridines.
    Milišiūnaitė V; Arbačiauskienė E; Řezníčková E; Jorda R; Malínková V; Žukauskaitė A; Holzer W; Šačkus A; Kryštof V
    Eur J Med Chem; 2018 Apr; 150():908-919. PubMed ID: 29602037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents.
    Barghash RF; Eldehna WM; Kovalová M; Vojáčková V; Kryštof V; Abdel-Aziz HA
    Eur J Med Chem; 2022 Jan; 227():113952. PubMed ID: 34731763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, anticancer assessment on human breast, liver and colon carcinoma cell lines and molecular modeling study using novel pyrazolo[4,3-c]pyridine derivatives.
    Metwally NH; Deeb EA
    Bioorg Chem; 2018 Apr; 77():203-214. PubMed ID: 29367077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors.
    Hassan GS; Georgey HH; Mohammed EZ; George RF; Mahmoud WR; Omar FA
    Eur J Med Chem; 2021 Jun; 218():113389. PubMed ID: 33784602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
    Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
    Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel pyrazolo[3,4-b]pyridines as cis-restricted combretastatin A-4 analogues.
    Jian XE; Yang F; Jiang CS; You WW; Zhao PL
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127025. PubMed ID: 32063430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
    Nagender P; Malla Reddy G; Naresh Kumar R; Poornachandra Y; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2905-8. PubMed ID: 24835633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of pyrazolo[3,4-b]pyridines under microwave irradiation in multi-component reactions and their antitumor and antimicrobial activities - Part 1.
    El-borai MA; Rizk HF; Abd-Aal MF; El-Deeb IY
    Eur J Med Chem; 2012 Feb; 48():92-6. PubMed ID: 22178093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4-b]pyridines with potential p38α MAPK-inhibitory activity.
    Farahat AA; Samir EM; Zaki MY; Serya RAT; Abdel-Aziz HA
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100302. PubMed ID: 34796536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
    Poreba K; Wietrzyk J; Opolski A
    Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
    Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
    Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel hydrazone and azole functionalized pyrazolo[3,4-b]pyridine derivatives as promising anticancer agents.
    Nagender P; Naresh Kumar R; Malla Reddy G; Krishna Swaroop D; Poornachandra Y; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4427-4432. PubMed ID: 27528432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,5-Diaryl-1H-pyrazolo[3,4-b]pyridines as potent tubulin polymerization inhibitors: Rational design, synthesis and biological evaluation.
    Zhai M; Liu S; Gao M; Wang L; Sun J; Du J; Guan Q; Bao K; Zuo D; Wu Y; Zhang W
    Eur J Med Chem; 2019 Apr; 168():426-435. PubMed ID: 30831410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel 1,2,3-triazole tagged pyrazolo[3,4-b]pyridine derivatives and their cytotoxic activity.
    Kurumurthy C; Veeraswamy B; Sambasiva Rao P; Santhosh Kumar G; Shanthan Rao P; Loka Reddy V; Venkateswara Rao J; Narsaiah B
    Bioorg Med Chem Lett; 2014 Feb; 24(3):746-9. PubMed ID: 24424132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents.
    Farag AM; Ali KA; El-Debss TM; Mayhoub AS; Amr AG; Abdel-Hafez NA; Abdulla MM
    Eur J Med Chem; 2010 Dec; 45(12):5887-98. PubMed ID: 20950898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and bioevaluation of N-(3,4,5-trimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-amines as tubulin polymerization inhibitors with anti-angiogenic effects.
    Hao SY; Qi ZY; Wang S; Wang XR; Chen SW
    Bioorg Med Chem; 2021 Feb; 31():115985. PubMed ID: 33421913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.